[ Global navigation starts here]

[ Skip global navigation and read the article ]

[ Skip global navigation and go to local navigation ]

Zeria Pharmaceutical Co., Ltd.
Site Map Japanese
ZERIA Pharmaceutical Co.,Ltd.
Search
Top  Corporate Profile  Financial Data  Main Products

[ Local navigation from here ]

[ A local navigation must fly and to the text ]

Financial Data
 Financial Data
 Top  >  Financial Data

Financial Summary


For the fiscal year ended March 31, 2008
pdf  Financial Summary (PDF/109KB)

For the fiscal year ended March 31, 2007
pdf  Financial Summary (PDF/96KB)

For the interim period of fiscal year ending March 31, 2007
pdf  Consolidated Financial Summary (PDF/163KB)
pdf  Non-consolidated Financial Summary (PDF/139KB)

For the fiscal year ended March 31,2006
pdf  Consolidated Financial Summary (PDF/141KB)
pdf  Non-consolidated Financial Summary (PDF/151KB)

For the interim period of fiscal year ending March 31,2006
pdf  Consolidated Financial Summary (PDF/72KB)
pdf  Non-consolidated Financial Summary (PDF/71KB)

For the fiscal year ended March 31,2005
pdf  Consolidated Financial Summary (PDF/67KB)
pdf  Non-consolidated Financial Summary (PDF/64KB)


Business Report


For the fiscal year ended March 31,2007
pdf  53rd Business Report (From April 1,2006 to March 31,2007.) (PDF/354KB)

For the fiscal year ended March 31,2006
pdf  52nd Business Report (From April 1,2005 to March 31,2006.) (PDF/236KB)



Selected Financial Data

[   ]···Consolidated
Fiscal year ended March
2005
March
2006
March
2007
March
2008
March
2009
March
2010
54,718
[ 56,209 ]
54,344
[ 55,545 ]
52,025
[ 52,757 ]
48,931
[ 49,721 ]
46,670
[ 47,670 ]
47,861
[ 50,745 ]
1,562
[ 1,999 ]
1,699
[ 1,879 ]
3,311
[ 3,341 ]
2,194
[ 2,446 ]
1,249
[ 1,366 ]
1,310
[ 1,467 ]
1,318
[ 1,385 ]
1,300
[ 1,248 ]
2,149
[ 2,068 ]
1,534
[ 1,639 ]
1,160
[ 1,203 ]
878
[ 1,001 ]
Capital stock (million yen) 6,593 6,593 6,593 6,593 6,593 6,593
No. of shares issued (1,000 shares) 48,290 48,290 48,290 48,290 48,290 48,290
30.24
[ 31.77 ]
30.44
[ 29.23 ]
50.88
[ 48.96 ]
36.64
[ 39.15 ]
27.87
[ 28.91 ]
21.23
[ 24.21 ]
4.7
[ 4.9 ]
4.6
[ 4.4 ]
7.4
[ 7.0 ]
5.3
[ 5.6 ]
4.2
[ 4.2 ]
3.2
[ 3.6 ]
Dividend payout ratio (%) 52.9 52.6 31.4 43.7 57.4 75.4
No. of employees 1,225
[ 1,270 ]
1,170
[ 1,216 ]
1,134
[ 1,171 ]
1,095
[ 1,131 ]
1,065
[ 1,159 ]
1,073
[ 1,280 ]
27,199
[ 27,715 ]
28,889
[ 29,353 ]
29,214
[ 29,597 ]
28,474
[ 28,962 ]
27,182
[ 27,711 ]
27,292
[ 27,995 ]
52,704
[ 55,162 ]
54,389
[ 56,539 ]
56,539
[ 58,519 ]
54,205
[ 56,424 ]
55,581
[ 58,110 ]
66,735
[ 70,971 ]
Plant and equipment investment (million yen)
Tangible and intangible long-term prepaid expenses
6,530
[6,640]
2,723
[ 2,725 ]
3,646
[ 3,651 ]
1,299
[ 1,427 ]
1,346
[ 1,379 ]
857
[ 1,844 ]
Depreciation (million yen)
Tangible and intangible long-term prepaid expenses
1,061
[ 1,080 ]
1,426
[ 1,448 ]
1,587
[ 1,609 ]
2,058
[ 2,080 ]
2,192
[ 2,234 ]
2,202
[ 2,313 ]
R&D (million yen) 6,545
[ 6,553 ]
6,768
[ 6,773 ]
5,767
[ 5,772 ]
5,381
[5,387 ]
5,122
[5,128 ]
5,589
[5,865 ]
Ratio of shareholders' equity to total assets (%) 51.6
[ 50.2 ]
53.1
[ 51.9 ]
51.7
[ 50.6 ]
52.5
[ 51.3 ]
48.9
[ 47.7 ]
40.9
[ 39.4 ]
640.31
[ 652.45 ]
680.29
[ 691.22 ]
694.46
[ 703.57 ]
683.35
[ 695.05 ]
656.92
[ 669.72 ]
659.77
[ 676.77 ]
Dividends per share (yen)
(of which, interim dividends per share)
16.00
(8.00)
16.00
(8.00)
16.00
(8.00)
16.00
(8.00)
16.00
(8.00)
16.00
(8.00)
2.4
[ 2.5 ]
2.4
[ 2.2 ]
4.1
[ 3.9 ]
3.1
[ 3.2 ]
2.4
[ 2.5 ]
1.8
[ 2.0 ]



Cash Flow

[   ]···Consolidated
Fiscal year ended March
2005
March
2006
March
2007
March
2008
March
2009
March
2010
Cash flow from business activities
(million yen)
3,468 1,265 2,749 3,759 423 5,858
Cash flow from investment activities
(million yen)
△8,109 △2,031 △4,876 △2,096 △3,363 △15,479
Cash flow from financial activities
(million yen)
5,303 △4 2,136 △1,335 △3,258 10,373

Top
Terms of use Personal Information Protection Policy
  Zeria Pharmaceutical Co., Ltd. 10-11, Nihonbashi, Kobuna-cho, Chuo-ku, Tokyo 103-8351, Japan  
Copyright (c) ZERIA Pharmaceutical Co.,Ltd. All Rights Reserved.